Jérôme Rapion

466 total citations
5 papers, 160 citations indexed

About

Jérôme Rapion is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jérôme Rapion has authored 5 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in Jérôme Rapion's work include interferon and immune responses (1 paper), Acute Myeloid Leukemia Research (1 paper) and Cancer Risks and Factors (1 paper). Jérôme Rapion is often cited by papers focused on interferon and immune responses (1 paper), Acute Myeloid Leukemia Research (1 paper) and Cancer Risks and Factors (1 paper). Jérôme Rapion collaborates with scholars based in Belgium, Netherlands and Italy. Jérôme Rapion's co-authors include Jan Bogaerts, Patrick Schöffski, Holger Fritsch, Étienne Brain, Isabelle Ray‐Coquard, Gerd Munzert, Jacques De Grève, Jean‐Pascal Machiels, Gertraud Hanft and Christel Fontaine and has published in prestigious journals such as European Journal of Cancer, Psycho-Oncology and Cancer Immunology Immunotherapy.

In The Last Decade

Jérôme Rapion

5 papers receiving 156 citations

Peers

Countries citing papers authored by Jérôme Rapion

Since Specialization

Citations

This map shows the geographic impact of Jérôme Rapion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Rapion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Rapion more than expected).

Fields of papers citing papers by Jérôme Rapion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Rapion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Rapion. The network helps show where Jérôme Rapion may publish in the future.

Co-authorship network of co-authors of Jérôme Rapion

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Rapion. A scholar is included among the top collaborators of Jérôme Rapion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Rapion. Jérôme Rapion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial) 2014 ·Annals of Hematology ·Roel Willemze, Stefan Suciu, Petra Muus, Constantijn J.M. Halkes, Giovanna Meloni, Liv Meert, Matthias Karrasch, Jérôme Rapion, Marco Vignetti, Sergio Amadori, T. de Witte, J. P. Marie	5
2	Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study) 2013 ·Cancer Immunology Immunotherapy ·Antonia Busse, Jérôme Rapion, Alberto Fusi, Stefan Suciu, Anika Nonnenmacher, Mario Santinami, Wim H.J. Kruit, Alessandro Testori, Cornelis J.A. Punt, Angus Dalgleish, Alan Spatz, Alexander Eggermont, Ulrich Keilholz	5
3	Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98 2013 ·Psycho-Oncology ·Elżbieta Senkus, Henry Gómez, Luc Dirix, Guy Jérusalem, Elizabeth Murray, Geertjan van Tienhoven, A. Helen Westenberg, Andrew Bottomley, Jérôme Rapion, Jan Bogaerts, Angelo Di Leo, Zora Nešković‐Konstantinović	50
4	Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century 2012 ·European Journal of Cancer Supplements ·Laurence Collette, Jan Bogaerts, Stefan Suciu, Catherine Fortpied, Thierry Gorlia, Corneel Coens, Murielle Mauer, Baktiar Hasan, Sandra Collette, M. Ouali, Saskia Litière, Jérôme Rapion, Richard Sylvester	5
5	Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI) 2010 ·European Journal of Cancer ·Patrick Schöffski, Jean‐Yves Blay, Jacques De Grève, Étienne Brain, Jean‐Pascal Machiels, Jean‐Charles Soria, Stefan Sleijfer, Pascal Wolter, Isabelle Ray‐Coquard, Christel Fontaine, Gerd Munzert, Holger Fritsch, Gertraud Hanft, (unknown), Jérôme Rapion, Anouk Allgeier, Jan Bogaerts, Denis Lacombe	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact